MedTrace Logo

Healthy Options: Group Psychotherapy for HIV-positive Depressed Perinatal Women.

NCT02039973 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 742

Last updated 2018-02-22

No results posted yet for this study

Summary

Although there is a significant burden of depression among HIV-positive women in Tanzania, there is a critical gap between the needs of this population and the integration of mental health and PMTCT-plus services. The long-term intent of the research is to bridge this gap with the overall goal to examine the potential for successful integration of enhanced mental health care and brief group interventions among HIV-positive women receiving PMTCT-plus services and to evaluate a combination of evidence-based approaches for treatment of depression in this vulnerable population in Tanzania.

Conditions

Interventions

BEHAVIORAL

Task-sharing approach to group therapy

Participants will also identify, select and clarify common concerns/problems; provide orientation to steps in problem-solving; break down identified problems into manageable pieces; choose pieces of problem to address in facilitated discussion of problem solving for implementing solutions; support the sharing of feedback of strategies used in problem-solving and maintaining pleasurable activities. Additionally, the intervention to aim to effect behavior by: explaining the links between problems, negative thoughts, choices made on a day-to-day basis, behaviors, and mood (symptoms of depression); facilitate sharing of practical skills to tackle problems, to change mood-related thoughts, choices and/or behaviors; offer and provide feedback on homework assignments to encourage practice of skills; and help participants attribute reported improvements to the use of new skills during feedback sessions.

BEHAVIORAL

Enhanced standard of care

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Harvard Medical School (HMS and HSDM)

    lead OTHER

Principal Investigators

  • Mary Kay Smith-Fawzi, ScD · Harvard Medical School (HMS and HSDM)

  • Sylvia Kaaya, MD, PhD · Muhimbili University of Health and Allied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-01
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02039973 on ClinicalTrials.gov